Literature DB >> 1716846

Enalaprilat versus cilazaprilat: a comparison of allergic skin reactions in the guinea pig.

K M Persson1, R G Andersson.   

Abstract

ACE-inhibitors have for some time been used in the treatment of hypertension. Apart from inhibiting the conversion of angiotensin I to II, the drugs also affect the metabolism of some inflammatory agents, like bradykinin and substance P. Egg albumin (EA)-sensitized guinea pigs were pretreated with the ACE-inhibitors. Measurement of flare and wheal areas induced by an intradermal injection of EA, showed that enalaprilat significantly increased, whereas cilazaprilat slightly decreased, the reaction area. Enalaprilat also showed an enhancement in histamine and substance P (SP) contents in the skin. In vitro incubation of guinea pig biopsies with enalaprilat potentiated EA- but not SP-induced histamine release. The EA-induced effect was abolished if the animals were pretreated with capsaicin. The conclusion is that cilazaprilat, in contrast to enalaprilat, does not potentiate inflammatory reactions in the guinea pig.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716846     DOI: 10.1007/bf01993137

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  4 in total

1.  Increased sensitivity of the enzymatic isotopic assay of histamine: measurement of histamine in plasma and serum.

Authors:  R E Shaff; M A Beaven
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

2.  Substance P degradation by rat brain peptidases: inhibition by SQ 20881.

Authors:  C M Lee; A Arregui; L L Iversen
Journal:  Biochem Pharmacol       Date:  1979       Impact factor: 5.858

3.  The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation.

Authors:  J K Wilkin; J J Hammond; W M Kirkendall
Journal:  Arch Dermatol       Date:  1980-08

Review 4.  Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review.

Authors:  B R Lindgren; R G Andersson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.